UnknownPhase 3NCT03899584

High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Coordinación de Investigación en Salud, Mexico
Principal Investigator
Martín Paredes Cruz, MSc
Instituto Mexicano del Seguro Social
Intervention
4-Aminopyridine(drug)
Enrollment
150 enrolled
Eligibility
18-60 years · All sexes
Timeline
20192023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03899584 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials